← Back to Clinical Trials
Recruiting NCT05981664

NCT05981664 Level Up! Adaptive Gaming for Children With Upper Limb Differences

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05981664
Status Recruiting
Phase
Sponsor University of Manitoba
Condition Upper Limb Amputation at the Wrist
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2024-01-01
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
One Handed Video Game Controller Adapter

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2024-01-01 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to test a new one-handed video game controller adapter to determine if it helps improve how video games are played and enjoyed in children with an upper limb difference on one side. The main questions it aims to answer are: * Is performance improved while playing video games with the adapter? * Is user satisfaction or enjoyment improved while playing video games with the adapter? Participants will: * Answer questions about their limb difference and other demographics * Be interviewed about their current and past video game playing experiences * Learn how to use the adapter and have their performance with it evaluated * Take the adapter home to use for 1 week, and be asked to record their experiences * Have their performance with the adapter re-evaluated after a week of practice * Be interviewed about their experience with the adapter

Eligibility Criteria

Inclusion Criteria: * between the age of 7 and 17 years * has a unilateral limb difference * limb difference may be from any cause (congenital difference, traumatic loss, etc.) * limb difference may be of any level (partial hand, wrist disarticulation, transradial, elbow disarticulation, transhumeral, shoulder disarticulation) * ability to communicate in English * cognitive ability to follow instructions * eligible participants will be included regardless of history of prosthesis use * lives locally (Winnipeg) or willing and able to travel to Rehabilitation Centre for Children for 2 appointments Exclusion Criteria: * less than 7 or greater than 17 years of age * bilateral or no limb upper limb difference * inability to communicate in English * cognitive inability to follow instructions * unable or unwilling to attend 2 appointments at Rehabilitation Centre for Children

Contact & Investigator

Central Contact

Elizabeth Hammond, PT, PhD

✉ ehammond@rccinc.ca

📞 204-451-5702

Principal Investigator

Meghan C Guglich, C.P.(c), MSc.

PRINCIPAL INVESTIGATOR

Rehabilitation Centre for Children

Frequently Asked Questions

Who can join the NCT05981664 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 17 Years, studying Upper Limb Amputation at the Wrist. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05981664 currently recruiting?

Yes, NCT05981664 is actively recruiting participants. Contact the research team at ehammond@rccinc.ca for enrollment information.

Where is the NCT05981664 trial being conducted?

This trial is being conducted at Winnipeg, Canada.

Who is sponsoring the NCT05981664 clinical trial?

NCT05981664 is sponsored by University of Manitoba. The principal investigator is Meghan C Guglich, C.P.(c), MSc. at Rehabilitation Centre for Children. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology